BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28506936)

  • 1. Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores.
    Janella BL; Campos CM; Caixeta A; Almeida BO; Brito FS; Abizaid A; Perin MA
    EuroIntervention; 2017 Nov; 13(10):1177-1184. PubMed ID: 28506936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.
    Sebastian G; Pillai V; Manzil A; Damodara R; Kalra I; Abdul Z; Mathew O
    Indian Heart J; 2021; 73(5):555-560. PubMed ID: 34627568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
    Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
    Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
    EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery.
    Capodanno D; Giacoppo D; Dipasqua F; Miccichè E; Licitra C; Di Salvo ME; Francaviglia B; Grasso C; La Manna A; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E446-52. PubMed ID: 23592634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
    Song Y; Gao Z; Tang X; Ma Y; Jiang P; Xu J; Yao Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):40-47. PubMed ID: 28895284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Hara H; Kogame N; Takahashi K; Modolo R; Chichareon P; Tomaniak M; Ono M; Kawashima H; Gao C; Wang R; Valkov VD; Vom Dahl J; Steinwender C; Geisler T; Lemos Neto PA; Macaya Miguel C; Garg S; Jüni P; Hamm C; Steg PG; Valgimigli M; Vranckx P; Windecker S; Farooq V; Onuma Y; Serruys PW;
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):E516-E526. PubMed ID: 32294317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.
    Campos CM; van Klaveren D; Iqbal J; Onuma Y; Zhang YJ; Garcia-Garcia HM; Morel MA; Farooq V; Shiomi H; Furukawa Y; Nakagawa Y; Kadota K; Lemos PA; Kimura T; Steyerberg EW; Serruys PW
    Circ J; 2014; 78(8):1942-9. PubMed ID: 24998278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
    Scudeler TL; Farkouh ME; Hueb W; Rezende PC; Campolina AG; Martins EB; Godoy LC; Soares PR; Ramires JAF; Kalil Filho R
    BMJ Open; 2022 Sep; 12(9):e062378. PubMed ID: 36137633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.
    Vroegindewey MM; Schuurman AS; Oemrawsingh RM; van Geuns RJ; Kardys I; Ligthart J; Daemen J; Boersma E; Serruys PW; Akkerhuis KM
    PLoS One; 2018; 13(7):e0200076. PubMed ID: 29965993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of euroSCORE II in predicting long-term outcome after percutaneous catheter intervention for coronary triple vessel disease or left main stenosis.
    Zhao M; Stampf S; Valina C; Kienzle RP; Ferenc M; Gick M; Essang E; Nührenberg T; Büttner HJ; Schumacher M; Neumann FJ
    Int J Cardiol; 2013 Oct; 168(4):3273-9. PubMed ID: 23664045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of ACEF II score in patients with multi-vessel coronary artery disease undergoing one-stop hybrid coronary revascularization.
    Li Y; Li C; Feng D; Zhang Q; Li K; Liu Y; Yang X; Wang L
    BMC Cardiovasc Disord; 2021 Oct; 21(1):489. PubMed ID: 34629062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularization.
    Kovacic JC; Limaye AM; Sartori S; Lee P; Patel R; Chandela S; Trost B; Roy S; Harari R; Narechania B; Karajgikar R; Kim MC; Krishnan P; Moreno P; Baber U; Mehran R; Dangas G; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):855-68. PubMed ID: 23703934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.